Overview
Revenue for the global biotech industry has grown over the past five years and global investment in biotechnology has increased consistently, with much of the added R&D spending funneled into medical applications aimed at providing care for the aging global population. The industry is expected to continue prospering over the next five years. In this context, Finglobedirect, which has been providing company and financial information globally since two decades, brings out an analytical report - Global Biotech Business: Recent Growth and New Directions.

Objective
The objective of this report is to review and analyze the performance of the global biotech companies during the most recent 12 months based on financial data, business news, stock market returns, and other non-financial information not quantifiable.

Research Sources
Our research team has compiled financial information of global biotech companies throughout the year from reliable primary and secondary sources including company websites, press releases, and stock exchanges. Further, the business news have been compiled throughout the year from established news portals, regional and international primary news sources, business media sites, company websites and stock exchanges. Also, stock prices from global stock exchanges have been compiled to list out the top gainers/decliners of the year.

• Provides quarterly update with rolling 12 months of data to facilitate focused analysis
• Identifies the leading global biotech companies of most recent 12 months based on financial performance
• Identifies the leading global biotech companies of most recent 12 months based on type of business news
• Presents the top gainers and bottom decliners of most recent 12 months on the basis of comparative stock analysis
• Identifies capstone 100 global biotech companies of most recent 12 months based on analysis done by various attributes
• Identifies the leading products and brands of most recent 12 months for global biotech sector
• Presents the key policy implications and regulatory developments taken place in most recent 12 months in the global biotech sector

• 1.1.1: Top 100 fastest growing biotech companies
• 1.1.2: Top 100 most profitable biotech companies
• 1.1.3: Top 100 most efficient biotech companies
• 1.1.4: Top 100 most improved biotech companies

• 1.2.1: Leading 100 companies with major contracts/deals signed
• 1.2.2: Leading 100 companies with major mergers/acquisitions
• 1.2.3: Leading 100 companies with major expansions
• 1.2.4: Leading 100 companies with major joint ventures
• 1.2.5: Leading 100 companies with major innovations/R&D and product launches
• 1.2.6: Leading 100 companies with major management changes
• 1.2.7: Leading 100 companies with major future investments planned for coming years

• 1.3.1: Top 100 gainers/decliners each based on stock price changes compared to previous 12 months

• 3.1: Leading 100 multinational biotech companies in news
• 3.2: Leading 100 listed biotech companies in news
• 3.3: Leading 100 privately owned biotech companies in news
• 3.4: Leading 100 companies in news by sub industries
• 3.5: Leading 100 biotech companies with phama or medical device companies investment ties

• 4.1: Major 100 products with regulatory approvals received
• 4.2: Major 100 global brands in news in biotech sector
• 4.3: Major 100 patents filed by global biotech companies in year
• 4.4: Major 100 patients’ studies in works as of December 31

• 5.1: Leading 10 countries with most mergers and acquisitions
• 5.2: Leading 10 countries with most research and development
• 5.3: Leading 10 countries with most expansions
• 5.4: Leading 10 countries where regulatory approvals have been very strict

• Appendix 1: Major 100 products with multiple manufacturers in global biotech sector (generic vs brand names)
• Appendix 2: Major 100 R&D centers of global biotech companies
• Appendix 3: Major 100 distributors worldwide of global biotech products
• Appendix 4: Major 100 suppliers of global biotech industry
• Appendix 5: Major 100 buyers of global biotech industry
• Appendix 6: Major 100 advertisers of global biotech sector
• Appendix 7: Major 100 PR/IR agencies of global biotech companies
• Appendix 8: Major 100 medical advisory boards of global biotech companies

• Company analysts with years of experience have analyzed the global biotech companies
• In-depth review and analysis of global biotech companies by various attributes
• An efficient process wherein same companies emerging as leading by various attributes are highlighted
• Reveals the leaders in the global biotech sector for most recent 12 months

Research Report: Global Biotech Business: Recent Growth and New Directions: $500

Select Product Global Biotech Business: Recent Growth and New Directions

Select Price $500

$950 for all three publications: Global Biotech series on Analysis/Investors Presentations (savings of $245)

• Global Biotech Business: Recent Growth and New Directions $500
• Global Biotech 500: Analysis of Quarterly Earnings (3rd Quarter 2015) $400
• Global Biotech: Investor Presentations( 50 companies) $295

Select Product Global Biotech series on Analysis/Investors Presentations

Select Price $950

Please send us an email for any further queries to info@finglobedirect.com.